RedShift BioAnalytics Announces Launch of Aurora

RedShiftBio has announced the launch of the new Aurora, purpose-built to deliver higher order structure measurements of biomolecules from one drop of sample (50μL). Powered by Microfluidic Modulation Spectroscopy (MMS) technology, this compact, all-in-one system with integrated touchscreen is now more affordable and uses minimal sample volume when compared to the first generation AQS3 Pro and Apollo instruments.

MMS combines a laser, a microfluidic flow cell, and a powerful software package to produce high resolution secondary structure information about your biomolecules of interest. This novel and fully-automated technique generates ultra-sensitive and precise structural measurements of your biomolecules, including proteins, nucleic acids, AAVs, biotherapeutics, and binding events. MMS generates a high-resolution differential absorbance spectrum across the Amide I region. MMS directly addresses the limitations of traditional spectroscopic methods like CD and FTIR by enabling direct, label-free analysis over a wide concentration range in complex buffer formulations, without the need to buffer exchange or dilute your precious samples. Complete automation from sample analysis to data processing reduces user error – No spectroscopy expertise required.

Contact us for a demo today!